Goals / Objectives
The development of a novel mRNA platform that is cost efficient and thermostable will open the door for vaccinating production animals with this technology. Here, we will develop the platform for a bovine RSV F vaccine as a proof of priniciple for development of vaccines against this pathogen but also as a platform technology for other vaccines as well. Goal 1 will be development of the technology and Goal 2 will be testing for efficacy in vivo.

https://portal.nifa.usda.gov/web/crisprojectpages/1027610-novel-mrna-vaccine-technology-for-prevention-of-bovine-respiratory-syncytial-virus.html